The treatment of social phobia: A critical assessment

Acta Psychiatrica Scandinavica

Volumn 98, Issue 3, 1998, Pages 171-181

  Stravynski, A ^a,c   Greenberg, D ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Jerusalem Mental Health Center Ezrath Nashim   (Israel)

^c CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

Anxiolytics; Cognitive restructuring; Exposure; MAOIs; Review; Social phobia; Social skills training; SSRIs

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; ATENOLOL; BROFAROMINE; BUSPIRONE; CLONAZEPAM; FLUVOXAMINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY; AVOIDANCE BEHAVIOR; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG EFFICACY; EXPOSURE; HUMAN; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; REVIEW; SOCIAL ADAPTATION; SOCIAL PHOBIA;

EID: 0031753663     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1998.tb10063.x     Document Type: Review

References (68)

1. TURNER SM, BLIDEL DC, TOWNSLEY RM. Social phobia: relationship to shyness. Behav Res Ther 1990: 28: 497-505.
2. STRAVYNSKI A, GREENBERG D. Behavioural psychotherapy for social phobia and dysfunction. Int Rev Psychiatry 1989: 1: 207-218.
3. SCHNEIER FR, HECKELMAN LR, GARFINKER R et al. Functional impairment in social phobia. J Clin Psychiatry 1994: 55: 322-331.
4. DAVIDSON JRT, HUGHES D-L, GEORGE L-K et al. The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychol Med 1993: 23: 709-718.
5. VAN AMERINGEN M, MANCINI C, STYAN G et al. Relationship of social phobia with other psychiatric illness. J Affect Disord 1991: 21: 93-99.
6. STRAVYNSKI A, LAMONTAGNE Y, LAVALLÉE YJ. Clinical phobias and avoidant personality disorder among alcoholics admitted to an alcoholism rehabilitation setting. Can J Psychiatry 1986: 31: 714-719.
7. KESSLER RC, GONAGLE K-A, ZHAO S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994: 51: 8-19.
8. SCHNEIER FR, JOHNSON J, HORNIG C-D et al. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992: 49: 282-287.
9. WEISSMAN MM, BLAND RC, CANINO GJ et al. The cross-national epidemiology of social phobia: a preliminary report. Int Clin Psychopharmacology 1996: 11: 9-14.
10. GOLDENBERG IM, WHITE K, YONKERS K et al. The infrequency of 'pure culture' diagnoses among the anxiety disorders. J Clin Psychiatry 1996: 57: 523-532.
11. SARTORIUS N, USTUN TB, KORTEN A et al. Progress toward achieving a common language in psychiatry. II. Results from the international field trials of the ICD-10 diagnostic criteria for research for mental and behavioral disorders. Am J Psychiatry 1995: 152: 1427-1437.
12. STRAVYNSKI A, BASOLGU M, MARKS M et al. The distinctiveness of phobias: a discriminant analysis of fears. J Anx Disord 1995: 9: 89-101.
13. STRAVYNSKI A, BASOGLU M, MARKS M et al. Social sensitivity: a shared feature of all phobias. Br J Clin Psychiatry 1995: 34: 343-351.
14. PELISSOLO A, LÉPINE J-P. Les phobies sociales: perspectives historiques et conceptuelles (Social phobias: historic and conceptual perspectives). L'Encéphale 1995: 21: 15-24.
15. MARKS IM. The classification of phobic disorders. Br J Psychiatry 1970: 118: 683-688.
16. TYRER P. Diagnostic anomalies in social phobia. Int Clin Psychopharmacology 1996: 11: 29-33.
17. HEIMBERG RG, HOLT CS, SCHNEIER FR et al. The issue of subtypes in the diagnosis of social phobia. J Anx Disord 1993: 7: 249-269.
18. TURNER RM. The effects of personality disorder diagnosis on the outcome of social anxiety symptom reduction. J Pers Disord 1987: 1: 136-143.
19. MILLON T, MARTINEZ A. Avoidant personality disorder. In: LIVESLEY WJ, ed. The DSM-IV personality disorders. New York: Guilford Press, 1995: 218-233.
20. STRAVYNSKI A, LELLIOTT P, MCNAMEE G et al. A typology of social phobia based on content of patients' complaints. 26th Congress of the European Association for Behaviour and Cognitive Therapy, Budapest, 2-5 October, 1996.
21. MANNUZZA S, SCHNEIER FR, CHAPMAN TF et al. Generalized social phobia: reliability and validity. Arch Gen Psychiatry 1995: 52: 230-237.
22. WIDIGER TA. Generalized social phobia versus avoidant personality disorder: a commentary on three studies. J Abnorm Psychol 1992: 101: 340-343.
23. BROWN EJ, HEIMBERG RG, HARLAN, RJ. Social phobia subtype and avoidant personality disorder: effect on severity of social phobia, impairment, and outcome of cognitive behavioral treatment. Behav Ther 1995: 26: 467-486.
24. TURNER AM, BEIDEL DC, WOLFF PL et al. Clinical features affecting treatment outcome in social phobia. Behav Res Ther 1996: 34: 795-804.
25. BEATTIE M, STEVENSON J. Measures of social functioning in psychiatric outcome research. Eval Rev 1984: 8: 631-644.
26. BUTLER G, CULLINGTON A, MUNBY M et al. Exposure and anxiety management in the treatment of social phobia. J Consult Clin Psychol 1984: 52: 642-650.
27. EMMELKAMP P, MERSCH P-P, VISSIA E et al. Social phobia: a comparative evaluation of cognitive and behavioural interventions. Behav Res Ther 1985: 23: 365-369.
28. MATTICK R-P, PETERS L. Treatment of severe social phobia: effects of guided exposure with and without cognitive restructuring. J Consult Clin Psychol 1988: 56: 251-260.
29. MATTICK R-P, PETERS L, CLARKE J-C. Exposure and cognitive restructuring for social phobia: a controlled study. Behav Ther 1989: 20: 3-23.
30. HEIMBERG RG, DODGE C-S, HOPE D-A et al. Cognitive behavioral group treatment for social phobia: comparison to a credible placebo control. Cogn Ther Res 1989: 14: 1-23.
31. HEIMBERG RG, SALZMAN DG, HOLT C-S et al. Cognitive-behavioral group treatment for social phobia: effectiveness at 5-year follow-up. Cogn Ther Res 1993: 17: 325-339.
32. SCHOLING A, EMMELKAMP PMG. Exposure with and without cognitive therapy for generalized social phobia: effects of individual and group treatment. Behav Res Ther 1993: 31: 667-681.
33. SCHOLING A, EMMELKAMP PMG. Treatment of generalized social phobia: results at long-term follow-up. Behav Res Ther 1996: 34: 447-452.
34. SCHOLING A, EMMELKAMP PMG. Cognitive and behavioural treatments of fear of blushing, sweating or trembling. Behav Res Ther 1993: 31: 155-170.
35. SCHOLING A, EMMELKAMP PMG. Treatment of fear of blushing, sweating and trembling: results at long-term follow-up. Behav Mod 1996: 20: 338-356.
36. MERSCH PPA. The treatment of social phobia: the differential effectiveness of exposure in vivo and an integration of exposure in vivo, rational-emotive therapy and social skills training. Behav Res Ther 1995: 33: 259-269.
37. MERSCH PPA, JANSEN MA, ARNTZ A. Social phobia and personality disorder: severity of complaint and treatment effectiveness. J Pers Disord 1995: 9: 143-159.
38. HOPE D, HEIMBERG R, BRUCH M. Dismantling cognitive-behavioral group therapy for social phobia. Behav Res Ther 1995: 33: 637-650.
39. TAYLOR S, WOODY S, KOCH WJ et al. Cognitive restructuring in the treatment of social phobia: efficacy and mode of action. Behav Mod 1997: 21: 487-511.
40. STRAVYNSKI A, MARKS I, YULE W. Social skills problems in neurotic outpatients. Arch Gen Psychiatry 1982: 39: 1378-1385.
41. MERSCH PPA, EMMELKAMP P-M-G, BOGELS S-M et al. Social phobia: individual response patterns and the effects of behavioral and cognitive interventions. Behav Res Ther 1989: 27: 421-434.
42. MERSCH PPA, EMMELKAMP P-M-G, LIPS C. Social phobia: individual response patterns and the effects of behavioral and cognitive interventions. A follow-up study. Behav Res Ther 1991: 29: 357-362.
43. WLAZLO Z, SCHROEDER-HARTIG K, HAND I et al. Exposure in vivo vs. social skills training for social phobia: long-term outcome and differential effects. Behav Res Ther 1990: 28: 181-193.
44. FAHLÉN T, NILSSON HL, BORG K et al. Social phobia: the clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine. Acta Psychiatr Scand 1995: 92: 351-358.
45. VAN VLIET IM, DEN BOER JA, WESTENBERG HGM. Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacology 1992: 2: 21-29.
46. LOTT M, GREIST JH, JEFFERSON JW et al. Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study. J Clin Psychopharmacology 1997: 17: 255-260.
47. VERSIANI M, NARDI AE, MUNDIM FD et al. Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1992: 161: 353-360.
48. BURROWS G, EVANS L, BAUMHACKL U et al. Moclobemide in social phobia: a double-blind, placebo-controlled clinical study. Eur Arch Psychiatry Clin Neurosci 1997: 247: 71-80.
49. NOYES R, MOROZ G, DAVIDSON JR et al. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacology 1997: 17: 247-254.
50. SCHNEIER FR, GOETZ D, CAMPEAS R et al. Placebo-controlled trial of moclobemide in social phobia. Br J Psychiatry 1998: 172: 70-77.
51. LIEBOWITZ MR, SCHNEIER F, CAMPEAS R et al. Phenelzine vs. atenolol in social phobia. Arch Gen Psychiatry 1992: 49: 290-300.
52. DAVIDSON JRT, POTTS N, RICHICHI E et al. Treatment of social phobia with clonazcpam and placebo. J Clin Psychopharmacology 1993: 13: 423-428.
53. DAVIDSON JRT, FORD SM, SMITH RD et al. Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 1991: 52: 16-20.
54. SUTHERLAND SM, TUPLER LA, COLKET JT et al. A 2-year follow-up of social phobia: status after a brief medication trial. J Nerv Ment Dis 1996: 184: 731-738.
55. VAN VLIET IM, DEN BOER JA, WESTENBERG HGM et al. Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study. J Clin Psychiatry 1997: 58: 164-168.
56. VAN VLIET IM, DEN BOER JA, WESTENBERG HGM. Psychopharmacological treatment of social phobia: a double-blind placebo-controlled study with fluvoxamine. Psychopharmacology 1994: 115: 128-134.
57. KATZELNICK DJ, KOBAK KA, GREIST JH et al. Sertraline for social phobia: a double-blind placebo-controlled crossover study. Am J Psychiatry 1995: 152: 1368-1371.
58. FALLOON I, LLOYD G-G, HARPIN R-E. The treatment of social phobia: real-life rehearsal with non-professional therapists. J Nerv Ment Dis 1981: 169: 180-184.
59. GELERNTER CS, UHDE T-W, CIMBOLIC P et al. Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Arch Gen Psychiatry 1991: 48: 938-945.
60. CLARK DB, AGRAS WS. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 1991: 148: 598-605.
61. TURNER SM, BEIDEL DC, JACOB RG. Social phobia: a comparison of behavior therapy and atenolol. J Consult Clin Psychol 1994: 62: 350-358.
62. MARKS IM. Fears, phobias and rituals. New York: Oxford University Press, 1987.
63. MCFALL RM. A review and reformulation of the concept of social skills. Behav Assess 1982: 4: 1-33.
64. KOPELOWICZ A, LIBERMAN R. Biobehavioral treatment and rehabilitation of schizophrenia. Harv Rev Psychiatry 1995: 3: 55-64.
65. KIRKBY KC. Computer-assisted treatment of phobias. Psychiatr Serv 1996: 47: 139-142.
66. MARKS IM. Behavior therapy as an aid to self-care. Curr Dir Psychiatr Sci 1994: 3: 19-22.
67. SHEEHAN DV, HARNETT-SHEEHAN K, RAJ BA. The measurement of disability. Int Clin Psychopharmacology 1996: 11: 89-95.
68. PATO MT, ZOHAR-KADOUCH R, ZOHAR J et al. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry 1988: 145: 1521-1525.